adamantane has been researched along with Vascular Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentley, P; Burkey, B; Busch, S; Chibout, SD; Dubost, V; Flavahan, N; Hayes, M; Hoffmann, P; Kaushik, V; Lapadula, D; Longo, L; Martin, L; Moulin, P; Pantano, S; Sahota, P; Schoenfeld, H; Spaet, R; Zhou, W | 1 |
| Matsui, T; Nishino, Y; Takeuchi, M; Yamagishi, S | 1 |
2 other study(ies) available for adamantane and Vascular Injuries
| Article | Year |
|---|---|
Vascular origin of vildagliptin-induced skin effects in Cynomolgus monkeys: pathomechanistic role of peripheral sympathetic system and neuropeptide Y.
Topics: Adamantane; Administration, Oral; Animals; Blood Pressure; Cold Temperature; Dipeptidases; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Macaca fascicularis; Neuropeptide Y; Nitriles; Norepinephrine; Pyrrolidines; Skin; Skin Diseases; Stress, Physiological; Vascular System Injuries; Vasoconstriction; Vildagliptin | 2014 |
Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis.
Topics: Adamantane; Animals; Aorta, Thoracic; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glycation End Products, Advanced; Male; Nitriles; Obesity; Pyrrolidines; Rats; Rats, Inbred OLETF; Vascular System Injuries; Vildagliptin | 2011 |